Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (152) 152
clinical neurology (122) 122
index medicus (115) 115
male (107) 107
female (103) 103
parkinson's disease (95) 95
aged (88) 88
middle aged (80) 80
article (62) 62
dementia (53) 53
neurosciences (44) 44
neurology (42) 42
parkinson disease - complications (39) 39
neuropsychological tests (34) 34
parkinson disease - diagnosis (32) 32
parkinsons disease (31) 31
adult (28) 28
parkinson’s disease (28) 28
aged, 80 and over (27) 27
alzheimer's disease (27) 27
diagnosis (27) 27
alzheimers-disease (26) 26
cognition (26) 26
abridged index medicus (23) 23
biomarkers (23) 23
parkinson disease - physiopathology (23) 23
cognition disorders - etiology (22) 22
parkinson disease - drug therapy (22) 22
severity of illness index (21) 21
movement disorders (20) 20
neurodegenerative diseases (20) 20
pathology (20) 20
risk factors (20) 20
cohort studies (19) 19
depression (19) 19
parkinson disease - psychology (19) 19
parkinson disease - genetics (18) 18
alpha-synuclein (17) 17
further section (17) 17
impairment (17) 17
medical research (17) 17
cognitive impairment (16) 16
cognitive ability (15) 15
disease progression (15) 15
parkinson disease - epidemiology (15) 15
reproducibility of results (15) 15
analysis (14) 14
cognition disorders - diagnosis (14) 14
dopamine (14) 14
medicine, experimental (14) 14
parkinson disease (14) 14
prevalence (14) 14
risk (14) 14
brain (13) 13
mental disorders (13) 13
sleep behavior disorder (13) 13
surveys and questionnaires (13) 13
cross-sectional studies (12) 12
double-blind method (12) 12
genotype (12) 12
lewy bodies (12) 12
association (11) 11
case-control studies (11) 11
parkinson disease - diagnostic imaging (11) 11
parkinson disease - therapy (11) 11
psychiatry (11) 11
sensitivity and specificity (11) 11
treatment outcome (11) 11
alzheimers disease (10) 10
clinical trials (10) 10
dopamine transporter (10) 10
neuroimaging (10) 10
patients (10) 10
psychiatric status rating scales (10) 10
quality of life (10) 10
research (10) 10
tau (10) 10
analysis of variance (9) 9
disease (9) 9
dysfunction (9) 9
genetics (9) 9
levodopa (9) 9
magnetic resonance imaging (9) 9
medical colleges (9) 9
mutation (9) 9
neuropsychology (9) 9
olfaction (9) 9
parkinsons-disease (9) 9
proteins (9) 9
quality-of-life (9) 9
activities of daily living (8) 8
cognition & reasoning (8) 8
disruptive, impulse control, and conduct disorders - etiology (8) 8
epidemiology (8) 8
executive function (8) 8
memory (8) 8
mental status schedule (8) 8
mild cognitive impairment (8) 8
neurodegeneration (8) 8
rating-scale (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders
by Coughlin, David and Xie, Sharon X and Liang, Mendy and Williams, Andrew and Peterson, Claire and Weintraub, Daniel and McMillan, Corey T and Wolk, David A and Akhtar, Rizwan S and Hurtig, Howard I and Branch Coslett, H and Hamilton, Roy H and Siderowf, Andrew D and Duda, John E and Rascovsky, Katya and Lee, Edward B and Lee, Virginia M.‐Y and Grossman, Murray and Trojanowski, John Q and Irwin, David J
Annals of Neurology, ISSN 0364-5134, 02/2019, Volume 85, Issue 2, pp. 259 - 271
Objective To use digital histology in a large autopsy cohort of Lewy body disorder (LBD) patients with dementia to test the hypotheses that co‐occurring... 
UNIVERSITY-OF-PENNSYLVANIA | NATIONAL INSTITUTE | ALZHEIMERS-DISEASE | IMAGE-ANALYSIS | BODIES | ALPHA-SYNUCLEIN | CLINICAL DIAGNOSTIC-CRITERIA | BRAIN PATHOLOGY | NEUROSCIENCES | CLINICAL NEUROLOGY | PARKINSONS-DISEASE DEMENTIA | NEUROPATHOLOGIC ASSESSMENT | Parkinson's disease | Cognitive ability | Synuclein | Heterogeneity | Histopathology | Autopsy | Cortex (frontal) | Dementia disorders | Amyloid | Alzheimer's disease | Movement disorders | Cortex (temporal) | Temporal lobe | Autopsies | Neurodegenerative diseases | Cortex | Histology | Patients | Putamen | Lewy bodies | Pathology | Cortex (entorhinal) | Tau protein | Correlation analysis | Cognitive tasks | Dementia
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Screening for impulse control symptoms in patients with de novo Parkinson disease: A casecontrol study
by Weintraub, Daniel and Papay, Kimberly and Siderowf, Andrew
Neurology, ISSN 0028-3878, 01/2013, Volume 80, Issue 2, pp. 176 - 180
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease
by Caspell-Garcia, Chelsea and Simuni, Tanya and Tosun-Turgut, Duygu and Wu, I-Wei and Zhang, Yu and Nalls, Mike and Singleton, Andrew and Shaw, Leslie A and Kang, Ju-Hee and Trojanowski, John Q and Siderowf, Andrew and Coffey, Christopher and Lasch, Shirley and Aarsland, Dag and Burn, David and Chahine, Lana M and Espay, Alberto J and Foster, Eric D and Hawkins, Keith A and Litvan, Irene and Richard, Irene and Weintraub, Daniel and Parkinson's Progression Marker and Parkinson’s Progression Markers Initiative (PPMI) and the Parkinson’s Progression Markers Initiative (PPMI)
PLoS ONE, ISSN 1932-6203, 05/2017, Volume 12, Issue 5, p. e0175674
Objectives To assess the neurobiological substrate of initial cognitive decline in Parkinson's disease (PD) to inform patient management, clinical trial... 
INITIATIVE PPMI | DEMENTIA | ALZHEIMERS-DISEASE | MULTIDISCIPLINARY SCIENCES | INCIDENT | DISORDER | POLYMORPHISM | DIAGNOSTIC-CRITERIA | PLANNING ABILITY | LEWY BODIES | DECLINE | Brain-Derived Neurotrophic Factor - genetics | Dopamine Plasma Membrane Transport Proteins - metabolism | Parkinson Disease - complications | Humans | Middle Aged | Tomography, Emission-Computed, Single-Photon | Male | tau Proteins - cerebrospinal fluid | Cognitive Dysfunction - cerebrospinal fluid | Catechol O-Methyltransferase - genetics | Diffusion Tensor Imaging | Magnetic Resonance Imaging | Cognitive Dysfunction - epidemiology | Aged, 80 and over | Amyloid beta-Peptides - cerebrospinal fluid | Adult | Cognitive Dysfunction - genetics | Female | Aged | Polymorphism, Single Nucleotide | Biomarkers - cerebrospinal fluid | Cognitive Dysfunction - diagnostic imaging | Complications and side effects | Care and treatment | Parkinson's disease | Development and progression | Cognition disorders | Biological markers | Identification and classification | Brain | Cognitive ability | Nervous system | Cerebrospinal fluid | Risk factors | Eye | Design | Computed tomography | Education | Aging | Alzheimer's disease | Public health | Movement disorders | Deoxyribonucleic acid--DNA | Apolipoprotein E4 | Emotional behavior | Temporal lobe | Neurodegenerative diseases | Catechol | Cortex (visual) | Single photon emission computed tomography | Substrates | Neurology | Pathology | Thinning | Experimental design | Biomarkers | β-Amyloid | Dementia | Neuroimaging | Haplotypes | Mental disorders | Laboratories | Parkinsons disease | Visual perception | Atrophy | Dementia disorders | Dopamine | Review boards | Health risks | Pharmacology | Dentistry | Medicine | Brain research | Sleep | Brain-derived neurotrophic factor | Magnetic resonance imaging | Parietal lobe | Alzheimers disease | Psychiatry | Polymorphism | Deoxyribonucleic acid | DNA
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Bridging the credibility gap in cost effectiveness analysis
by Siderowf, Andrew
Movement Disorders, ISSN 0885-3185, 02/2014, Volume 29, Issue 2, pp. 164 - 165
CLINICAL NEUROLOGY | PARKINSONS-DISEASE | Cost-Benefit Analysis - economics | Cost of Illness | Parkinson Disease - economics | Humans | Cost benefit analysis | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities
by Berg, Daniela, Prof and Lang, Anthony E, Prof and Postuma, Ronald B, MD and Maetzler, Walter, MD and Deuschl, Guenther, Prof and Gasser, Thomas, Prof and Siderowf, Andrew, MD and Schapira, Anthony H, Prof and Oertel, Wolfgang, Prof and Obeso, José A, Prof and Olanow, C Warren, Prof and Poewe, Werner, Prof and Stern, Matthew, Prof
Lancet Neurology, The, ISSN 1474-4422, 2013, Volume 12, Issue 5, pp. 514 - 524
Summary Recent findings question our present understanding of Parkinson's disease and suggest that new research criteria for the diagnosis of Parkinson's... 
Neurology | NEURODEGENERATIVE DISEASE | OLFACTORY DYSFUNCTION | CLINICAL-DIAGNOSIS | LRRK2 G2019S MUTATION | TRANSCRANIAL SONOGRAPHY | LEWY BODY DISEASE | ALPHA-SYNUCLEIN | SUBSTANTIA-NIGRA | CLINICAL NEUROLOGY | SLEEP BEHAVIOR DISORDER | REM-SLEEP | Parkinson Disease - diagnosis | Parkinson Disease - pathology | Research | Humans
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Biomarkers for atypical Parkinsonism: Some progress, but much work remains
by Feigin, Andrew and Siderowf, Andrew
Parkinsonism and Related Disorders, ISSN 1353-8020, 03/2018, Volume 48, pp. 1 - 2
POSITRON-EMISSION-TOMOGRAPHY | SUPRANUCLEAR PALSY | CLINICAL NEUROLOGY | DISEASE | Biomarkers - metabolism | Parkinsonian Disorders - metabolism | Humans | Parkinsonian Disorders - diagnosis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort
by Simuni, Tanya and Siderowf, Andrew and Lasch, Shirley and Coffey, Chris S and Caspell‐Garcia, Chelsea and Jennings, Danna and Tanner, Caroline M and Trojanowski, John Q and Shaw, Leslie M and Seibyl, John and Schuff, Norbert and Singleton, Andrew and Kieburtz, Karl and Toga, Arthur W and Mollenhauer, Brit and Galasko, Doug and Chahine, Lana M and Weintraub, Daniel and Foroud, Tatiana and Tosun, Duygu and Poston, Kathleen and Arnedo, Vanessa and Frasier, Mark and Sherer, Todd and Chowdhury, Sohini and Marek, Kenneth and Parkinson's Progression Marker Ini and Parkinson's Progression Marker Initiative
Movement Disorders, ISSN 0885-3185, 05/2018, Volume 33, Issue 5, pp. 771 - 782
ABSTRACT Objective: The objective of this study was to assess longitudinal change in clinical and dopamine transporter imaging outcomes in early, untreated PD.... 
gait disorder predominant | tremor dominant | Parkinson's disease | disease subtypes | postural instability | TRIALS | SCALE MDS-UPDRS | PPMI | SOCIETY-SPONSORED REVISION | CLINICAL NEUROLOGY | LEVODOPA | Medicine, Experimental | Medical research | Development and progression | Tremor | Dopamine | Neurodegenerative diseases | Parkinsons disease | Neostriatum | Dopamine transporter | Movement disorders | Dopamine receptors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Impulse control disorders in parkinson disease: A multicenter case–control study
by Voon, Valerie and Sohr, Mandy and Lang, Anthony E and Potenza, Marc N and Siderowf, Andrew D and Whetteckey, Jacqueline and Weintraub, Daniel and Wunderlich, Glen R and Stacy, Mark
Annals of Neurology, ISSN 0364-5134, 06/2011, Volume 69, Issue 6, pp. 986 - 996
Objective: To assess factors associated with impulse control disorders (ICDs) in Parkinson disease (PD) using a multicenter case–control design. Methods:... 
DEPRESSION | SYMPTOMS | ALCOHOL | ANXIETY | NEUROSCIENCES | CLINICAL NEUROLOGY | Disability Evaluation | Disruptive, Impulse Control, and Conduct Disorders - drug therapy | Parkinson Disease - complications | Cross-Sectional Studies | Levodopa - therapeutic use | Humans | Middle Aged | Dopamine Agonists - therapeutic use | Disruptive, Impulse Control, and Conduct Disorders - etiology | Male | Parkinson Disease - drug therapy | Case-Control Studies | Antiparkinson Agents - therapeutic use | Neuropsychological Tests | Psychiatric Status Rating Scales | Analysis of Variance | Cognition Disorders - etiology | Female | Aged | Medical research | Impulsivity | Parkinsons disease
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Striatal Dopamine Transporter Imaging Correlates with Anxiety and Depression Symptoms in Parkinson's Disease
by Weintraub, Daniel and Newberg, Andrew B and Cary, Mark S and Siderowf, Andrew D and Moberg, Paul J and Kleiner-Fisman, Galit and Duda, John E and Stern, Matthew B and Mozley, David and Katz, Ira R
The Journal of Nuclear Medicine, ISSN 0161-5505, 02/2005, Volume 46, Issue 2, pp. 227 - 232
We studied the correlation of striatal dopamine transporter (DAT) imaging with anxiety and depression symptoms in Parkinson's disease (PD). Methods: Patients... 
Depression | Dopamine transporter | Anxiety | Parkinson's disease | TRODAT-1 | SYSTEM | FRONTAL-LOBE | BASAL GANGLIA | DISORDERS | MAJOR DEPRESSION | PUTAMEN NUCLEI | COMORBIDITY | anxiety | dopamine transporter | PRAMIPEXOLE | depression | PERSONALITY-TRAITS | BINDING | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Membrane Glycoproteins - metabolism | Humans | Middle Aged | Male | Tropanes - pharmacokinetics | Statistics as Topic | Corpus Striatum - metabolism | Depression - etiology | Tissue Distribution | Depression - metabolism | Sensitivity and Specificity | Anxiety - diagnostic imaging | Anxiety - diagnosis | Female | Membrane Transport Proteins - metabolism | Parkinson Disease - metabolism | Anxiety - metabolism | Dopamine Plasma Membrane Transport Proteins | Severity of Illness Index | Parkinson Disease - complications | Reproducibility of Results | Parkinson Disease - diagnostic imaging | Radiopharmaceuticals - pharmacokinetics | Depression - diagnosis | Nerve Tissue Proteins - metabolism | Organotechnetium Compounds - pharmacokinetics | Radionuclide Imaging | Biomarkers | Depression - diagnostic imaging | Corpus Striatum - diagnostic imaging | Anxiety - etiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Screening for impulse control symptoms in patients with de novo Parkinson disease A case-control study
by Weintraub, D and Papay, K and Siderowf, A and Parkinson's Progression Markers and Parkinson's Progression Markers Initiative and for the Parkinson's Progression Markers Initiative
NEUROLOGY, ISSN 0028-3878, 01/2013, Volume 80, Issue 2, pp. 176 - 180
Objective: To determine the frequency and correlates of impulse control and related behavior symptoms in patients with de novo, untreated Parkinson disease... 
CONTROL DISORDERS | MOCA | DYSREGULATION | COGNITIVE IMPAIRMENT | PREVALENCE | BEHAVIORS | PROGRESSION | ONSET | CLINICAL NEUROLOGY | DOPAMINE AGONISTS | Parkinson Disease - complications | Gambling - psychology | Humans | Middle Aged | Disruptive, Impulse Control, and Conduct Disorders - etiology | Male | Risk | Disease Progression | Disruptive, Impulse Control, and Conduct Disorders - diagnosis | Neuropsychological Tests | Disruptive, Impulse Control, and Conduct Disorders - epidemiology | Psychiatric Status Rating Scales | Biomarkers | Parkinson Disease - diagnosis | Parkinson Disease - epidemiology | Female | Surveys and Questionnaires | Aged | Research Design | 165 | 199 | 205
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementia
by Akhtar, Rizwan S and Xie, Sharon X and Chen, Yin J and Rick, Jacqueline and Gross, Rachel G and Nasrallah, Ilya M and Van Deerlin, Vivianna M and Trojanowski, John Q and Chen-Plotkin, Alice S and Hurtig, Howard I and Siderowf, Andrew D and Dubroff, Jacob G and Weintraub, Daniel
PLoS ONE, ISSN 1932-6203, 05/2017, Volume 12, Issue 5, p. e0177924
Parkinson disease patients develop clinically significant cognitive impairment at variable times over their disease course, which is often preceded by milder... 
APOLIPOPROTEIN-E EPSILON-4 | POSITRON-EMISSION-TOMOGRAPHY | ALZHEIMERS-DISEASE | MULTIDISCIPLINARY SCIENCES | VOLUME EFFECT CORRECTION | IN-VIVO | A-BETA | ALPHA-SYNUCLEIN | DIAGNOSTIC-CRITERIA | FLORBETAPIR F 18 | PET | Parkinson Disease - pathology | Dementia - pathology | Humans | Middle Aged | Cognition Disorders - pathology | Cognition Disorders - metabolism | Male | Positron-Emission Tomography - methods | Alzheimer Disease - pathology | Brain - metabolism | Dementia - metabolism | Amyloid - metabolism | Alzheimer Disease - metabolism | Amyloid beta-Peptides - metabolism | Brain - pathology | Cognition - physiology | Female | Plaque, Amyloid - metabolism | Aged | Parkinson Disease - metabolism | Ethylene Glycols - administration & dosage | Aniline Compounds - administration & dosage | Amyloidogenesis | Brain | Parkinson's disease | Gait | Memory | Cognitive ability | Disorders | Nervous system | Cognition | Rigidity | Epidemiology | Freezing | Proteins | Autopsy | Education | Tomography | Aging | Alzheimer's disease | Movement disorders | Quantitative analysis | Binding | Apolipoprotein E4 | Neurodegenerative diseases | Cortex | Regression analysis | Assessments | Apolipoproteins | Emissions | Studies | Pathology | Neurology | Radiology | β-Amyloid | Cognitive tasks | Dementia | Neuroimaging | Nuclear medicine | Neurosciences | Mental disorders | Laboratories | Physicians | Parkinsons disease | Risk | Population studies | Accumulation | Apolipoprotein E | Dementia disorders | Qualitative analysis | Deposition | Autopsies | Medical imaging | Health risks | Medicine | Brain research | Cognition & reasoning | Magnetic resonance imaging | Gene frequency | Alleles | Amyloidosis | In vivo methods and tests | Reliability | Positron emission tomography | Psychiatry
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Association of cerebrospinal fluid β-amyloid 1-42, t-tau, p-tau 181 , and α-synuclein levels with clinical features of drug-naive patients with early parkinson disease
by Kang, Ju-Hee and Irwin, David J and Chen-Plotkin, Alice S and Siderowf, Andrew and Caspell, Chelsea and Coffey, Christopher S and Waligórska, Teresa and Taylor, Peggy and Pan, Sarah and Frasier, Mark and Marek, Kenneth and Kieburtz, Karl and Jennings, Danna and Simuni, Tanya and Tanner, Caroline M and Singleton, Andrew and Toga, Arthur W and Chowdhury, Sohini and Mollenhauer, Brit and Trojanowski, John Q and Shaw, Leslie M
JAMA Neurology, ISSN 2168-6149, 2013, Volume 70, Issue 10, pp. 1277 - 1287
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Premotor Parkinson's disease: Concepts and definitions
by Siderowf, Andrew and Lang, Anthony E
Movement Disorders, ISSN 0885-3185, 04/2012, Volume 27, Issue 5, pp. 608 - 616
Parkinson's disease (PD) has a prodromal phase during which nonmotor clinical features as well as physiological abnormalities may be present. These premotor... 
specificity | Parkinson's disease | early detection | sensitivity | Sensitivity | Specificity | Early detection | OLFACTORY DYSFUNCTION | POSITRON-EMISSION TOMOGRAPHY | DOPAMINERGIC FUNCTION | LEWY BODY DISEASE | SUBSTANTIA-NIGRA | HUNTINGTON DISEASE | CLINICAL NEUROLOGY | SLEEP BEHAVIOR DISORDER | CIGARETTE-SMOKING | ALPHA-SYNUCLEINOPATHY | CARDIAC UPTAKE | Parkinson Disease - therapy | Humans | Parkinson Disease - diagnosis | Parkinson Disease - classification | Parkinson Disease - genetics | Early Diagnosis | Motor Neurons - pathology | Parkinson Disease - etiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights